This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in November 2014 and give you an exclusive opportunity to gain discounted annual subscription access to our database.

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014.

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in September 2014.

Joint venture partnering is a specific type of deal whereby the parties to the deal agree to form a legal third party entity, normally under the joint control of the parties to the deal, to jointly fund and develop a compound, product or technology.

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.

An asset purchase agreement is an agreement between a buyer and a seller that finalizes terms and conditions related to the purchase and sale of life sciences company’s assets.

This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in August 2014.

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials

Recent trends in preclinical partnering for the top pharma and biotech companies reviewed, over 2,000 deals analyzed – including summary of biopharma deal financials

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced.